Literature DB >> 28280268

Oncogenic effects of PAFR ligands produced in tumours upon chemotherapy and radiotherapy.

Roger Chammas1, Luciana Nogueira de Sousa Andrade1, Sonia Jancar2.   

Abstract

Entities:  

Year:  2017        PMID: 28280268     DOI: 10.1038/nrc.2017.15

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


× No keyword cloud information.
  14 in total

1.  PAF receptor mediated PGE2 production in LPS primed P388D1 macrophage-like cells.

Authors:  K B Glaser; R Asmis; E A Dennis
Journal:  Adv Prostaglandin Thromboxane Leukot Res       Date:  1991

2.  Platelet-activating factor and metastasis: calcium-independent phospholipase A2β deficiency protects against breast cancer metastasis to the lung.

Authors:  Jane McHowat; Gail Gullickson; Richard G Hoover; Janhavi Sharma; John Turk; Jacki Kornbluth
Journal:  Am J Physiol Cell Physiol       Date:  2011-01-12       Impact factor: 4.249

3.  Blocking PGE2-induced tumour repopulation abrogates bladder cancer chemoresistance.

Authors:  Antonina V Kurtova; Jing Xiao; Qianxing Mo; Senthil Pazhanisamy; Ross Krasnow; Seth P Lerner; Fengju Chen; Terrence T Roh; Erica Lay; Philip Levy Ho; Keith Syson Chan
Journal:  Nature       Date:  2014-12-03       Impact factor: 49.962

Review 4.  A fate worse than death: apoptosis as an oncogenic process.

Authors:  Gabriel Ichim; Stephen W G Tait
Journal:  Nat Rev Cancer       Date:  2016-07-01       Impact factor: 60.716

Review 5.  Recent advances in molecular biology and physiology of the prostaglandin E2-biosynthetic pathway.

Authors:  Makoto Murakami; Ichiro Kudo
Journal:  Prog Lipid Res       Date:  2004-01       Impact factor: 16.195

6.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Authors:  Qian Huang; Fang Li; Xinjian Liu; Wenrong Li; Wei Shi; Fei-Fei Liu; Brian O'Sullivan; Zhimin He; Yuanlin Peng; Aik-Choon Tan; Ling Zhou; Jingping Shen; Gangwen Han; Xiao-Jing Wang; Jackie Thorburn; Andrew Thorburn; Antonio Jimeno; David Raben; Joel S Bedford; Chuan-Yuan Li
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

7.  LysoPC and PAF Trigger Arachidonic Acid Release by Divergent Signaling Mechanisms in Monocytes.

Authors:  Janne Oestvang; Marit W Anthonsen; Berit Johansen
Journal:  J Lipids       Date:  2011-09-11

8.  Expression of PAFR as part of a prosurvival response to chemotherapy: a novel target for combination therapy in melanoma.

Authors:  Ana Claudia Onuchic; Camila M L Machado; Renata F Saito; Francisco J Rios; Sônia Jancar; Roger Chammas
Journal:  Mediators Inflamm       Date:  2012-04-18       Impact factor: 4.711

9.  Clearance of apoptotic cells by macrophages induces regulatory phenotype and involves stimulation of CD36 and platelet-activating factor receptor.

Authors:  Matheus Ferracini; Francisco J O Rios; Mateus Pecenin; Sonia Jancar
Journal:  Mediators Inflamm       Date:  2013-11-20       Impact factor: 4.711

10.  Radiation therapy generates platelet-activating factor agonists.

Authors:  Ravi P Sahu; Kathleen A Harrison; Jonathan Weyerbacher; Robert C Murphy; Raymond L Konger; Joy Elizabeth Garrett; Helen Jan Chin-Sinex; Michael Edward Johnston; Joseph R Dynlacht; Marc Mendonca; Kevin McMullen; Gengxin Li; Dan F Spandau; Jeffrey B Travers
Journal:  Oncotarget       Date:  2016-04-12
View more
  4 in total

1.  Cancer therapy-induced PAFR ligand expression: any role for caspase activity?

Authors:  Gabriel Ichim; Stephen W G Tait
Journal:  Nat Rev Cancer       Date:  2017-03-10       Impact factor: 60.716

Review 2.  A matter of life and death: stem cell survival in tissue regeneration and tumour formation.

Authors:  Despina Soteriou; Yaron Fuchs
Journal:  Nat Rev Cancer       Date:  2018-01-19       Impact factor: 60.716

Review 3.  Platelet activating factor receptor antagonists improve the efficacy of experimental chemo- and radiotherapy.

Authors:  Ildefonso Alves da Silva Junior; Luciana Nogueira de Sousa Andrade; Sonia Jancar; Roger Chammas
Journal:  Clinics (Sao Paulo)       Date:  2018-10-11       Impact factor: 2.365

Review 4.  Phosphatidylcholine-Derived Lipid Mediators: The Crosstalk Between Cancer Cells and Immune Cells.

Authors:  Renata de Freitas Saito; Luciana Nogueira de Sousa Andrade; Silvina Odete Bustos; Roger Chammas
Journal:  Front Immunol       Date:  2022-02-15       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.